Yahoo Finance

Australian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors

STATEN ISLAND, N.Y., Oct. 9, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule ...

Acurx Pharmaceuticals (ACXP) Secures New US Patent for DNA Polymerase IIIC Inhibitors

Acurx Pharmaceuticals Inc. (NASDAQ:ACXP) is one of the best up and coming penny stocks to buy. On February 2, Acurx ...
Nasdaq

JPO Grants Acurx Pharmaceuticals Patent in Japan for DNA Polymerase IIIC Inhibitors

STATEN ISLAND, N.Y., Feb. 19, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small ...
Yahoo Finance

USPTO Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors

STATEN ISLAND, N.Y., Feb. 2, 2026 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule ...
Pharmabiz

Acurx Pharmaceuticals’ DNA Polymerase IIIC Inhibitors receives Japanese patent

Acurx Pharmaceuticals, Inc., a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections, announced that a new patent has ...
ドリームニュース

デオキシリボ核酸（DNA）ポリメラーゼ市場調査レポート - 世界市場 ...

SDKI Analytics（本社：東京都渋谷区）は、このたび、2025年01月25に「デオキシリボ核酸（DNA）ポリメラーゼ市場調査レポート：2025－2037年の市場規模、シェア、傾向の予測」を発表しました。デオキシリボ核酸（DNA）ポリメラーゼに関する市場調査レポートには ...